Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitochondrial Calcium Deregulation in the Mechanism of Beta-Amyloid and Tau Pathology
Noemí Esteras, Andrey Y. Abramov
Cells (2020) Vol. 9, Iss. 9, pp. 2135-2135
Open Access | Times Cited: 85

Showing 26-50 of 85 citing articles:

The impact of chelating compounds on Cu2+, Fe2+/3+, and Zn2+ ions in Alzheimer's disease treatment
Tomasz Mazur, Magdalena Malik, Dariusz C. Bieńko
Journal of Inorganic Biochemistry (2024) Vol. 257, pp. 112601-112601
Open Access | Times Cited: 7
The Complex Interplay between Toxic Hallmark Proteins, Calmodulin-Binding Proteins, Ion Channels, and Receptors Involved in Calcium Dyshomeostasis in Neurodegeneration
Danton H. O’Day
Biomolecules (2024) Vol. 14, Iss. 2, pp. 173-173
Open Access | Times Cited: 6
Molecular Dysfunctions of Mitochondria-Associated Membranes (MAMs) in Alzheimer’s Disease
Fanny Eysert, Paula Fernanda Kinoshita, Arnaud Mary, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9521-9521
Open Access | Times Cited: 47
Alterations of the Endoplasmic Reticulum (ER) Calcium Signaling Molecular Components in Alzheimer’s Disease
Mounia Chami, Frédéric Checler
Cells (2020) Vol. 9, Iss. 12, pp. 2577-2577
Open Access | Times Cited: 43
Structural and Functional Alterations in Mitochondria-Associated Membranes (MAMs) and in Mitochondria Activate Stress Response Mechanisms in an In Vitro Model of Alzheimer’s Disease
Tânia Fernandes, Rosa Resende, Diana F. Silva, et al.
Biomedicines (2021) Vol. 9, Iss. 8, pp. 881-881
Open Access | Times Cited: 37
Modulating mitochondrial calcium channels (TRPM2/MCU/NCX) as a therapeutic strategy for neurodegenerative disorders
Gretchen A. Johnson, Raghu R. Krishnamoorthy, Dorota L. Stankowska
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 14
Amyloids: The History of Toxicity and Functionality
Elmira I. Yakupova, L. G. Bobyleva, Sergey A. Shumeyko, et al.
Biology (2021) Vol. 10, Iss. 5, pp. 394-394
Open Access | Times Cited: 27
Beta-Amyloid Instigates Dysfunction of Mitochondria in Cardiac Cells
Sehwan Jang, Xavier R. Chapa‐Dubocq, Rebecca Parodi‐Rullán, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 373-373
Open Access | Times Cited: 22
Calcium signaling hypothesis: A non-negligible pathogenesis in Alzheimer’s disease
Minghui Wang, Hu Zhang, Jiling Liang, et al.
Journal of Advanced Research (2025)
Open Access
Ethanol extract of Moschus attenuates glutamate-induced cytotoxicity in HT22 cells by regulating the Nrf2 and MAPK pathway
Zhili Chu, Yubing Chen, Danni Xie, et al.
Journal of Ethnopharmacology (2025), pp. 119879-119879
Closed Access
Brain energy failure in dementia syndromes: Opportunities and challenges for glucagon‐like peptide‐1 receptor agonists
Hussein N. Yassine, Victoria Solomon, Angad Thakral, et al.
Alzheimer s & Dementia (2021) Vol. 18, Iss. 3, pp. 478-497
Open Access | Times Cited: 24
Current Progress on Neuroprotection Induced by Artemisia, Ginseng, Astragalus, and Ginkgo Traditional Chinese Medicines for the Therapy of Alzheimer’s Disease
Qin Li, Limor Rubin, Marta Silva, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-21
Open Access | Times Cited: 16
Oxazole-4-carboxamide/butylated hydroxytoluene hybrids with GSK-3β inhibitory and neuroprotective activities against Alzheimer's disease
Zhongwen Luo, Shang Li, Yonglei Zhang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115415-115415
Closed Access | Times Cited: 10
Calcium Ions in the Physiology and Pathology of the Central Nervous System
Damian Pikor, Mikołaj Hurła, Bartosz Słowikowski, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 13133-13133
Open Access | Times Cited: 3
Iron(ing) out parkinsonisms: the interplay of proteinopathy and ferroptosis in Parkinson’s disease and tau-related parkinsonisms
Maria João da Costa Caiado, Amalia M. Dolga, Wilfred F.A. den Dunnen
Redox Biology (2024) Vol. 79, pp. 103478-103478
Open Access | Times Cited: 3
Critical appraisal on mitochondrial dysfunction in Alzheimer’s disease
Faizan Ahmad, Punya Sachdeva
Aging Medicine (2022) Vol. 5, Iss. 4, pp. 272-280
Open Access | Times Cited: 15
Modulation of L-type calcium channels in Alzheimer’s disease: A potential therapeutic target
Chelsea Ann Crossley, Vishaal Rajani, Qi Yuan
Computational and Structural Biotechnology Journal (2022) Vol. 21, pp. 11-20
Open Access | Times Cited: 15
Mitochondrial Bioenergetics, Redox Balance, and Calcium Homeostasis Dysfunction with Defective Ultrastructure and Quality Control in the Hippocampus of Aged Female C57BL/6J Mice
Angie K. Torres, Claudia Jara, Jesús Llanquinao, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5476-5476
Open Access | Times Cited: 8
Infliximab and/or MESNA alleviate doxorubicin-induced Alzheimer's disease-like pathology in rats: A new insight into TNF-α/Wnt/β-catenin signaling pathway
Hoda E. Mohamad, Dina M. Abo‐Elmatty, Nehal S. Wahba, et al.
Life Sciences (2022) Vol. 301, pp. 120613-120613
Closed Access | Times Cited: 13
<italic>MCU</italic> knockdown in hippocampal neurons improves memory performance of an Alzheimer’s disease mouse model
Hong-Yan Cai, Jing Qiao, Siru Chen, et al.
Acta Biochimica et Biophysica Sinica (2022) Vol. 54, Iss. 10, pp. 1528-1539
Open Access | Times Cited: 13
Advances in the discovery of heterocyclic-based drugs against Alzheimer’s disease
J. Domingo Sánchez, Andrés R. Alcántara, Juan F. González, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 12, pp. 1413-1428
Closed Access | Times Cited: 7
Calcium Signalling in Alzheimer’s Disease: From Pathophysiological Regulation to Therapeutic Approaches
Mounia Chami
Cells (2021) Vol. 10, Iss. 1, pp. 140-140
Open Access | Times Cited: 16
Neuroepigenetic Mechanisms of Action of Ultrashort Peptides in Alzheimer’s Disease
Anastasiia Ilina, Khavinson VKh, N. S. Linkova, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4259-4259
Open Access | Times Cited: 11
Pharmacological sequestration of mitochondrial calcium uptake protects against dementia and β-amyloid neurotoxicity
E. F. Shevtsova, Plamena R. Angelova, Olga Stelmashchuk, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 11
Hippocampal metabolic subregions and networks: Behavioral, molecular, and pathological aging profiles
Somayeh Maleki Balajoo, Simon B. Eickhoff, Shahrzad Kharabian Masouleh, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 11, pp. 4787-4804
Open Access | Times Cited: 6

Scroll to top